News | June 11, 2014

Dutch Cancer Patients to Benefit From Erasmus Medical Center's New Linacs

Largest medical center in the Netherlands upgrades with several Elekta Versa HD linear accelerators

June 11, 2014 — Erasmus University Medical Center (Erasmus MC) in Rotterdam, the Netherlands, announced the purchase of Elekta Versa HD linear accelerators (linacs) and a software upgrade including the Mosaiq oncology information system (OIS) and Monaco 5 treatment planning system.

The advanced Versa HD linac system is designed to improve patient care and treat a broad spectrum of cancers. Its high precision and unique beam shaping technology increases tumor targeting, with the aim of delivering better outcomes for cancer patients.

According to Comprehensive Cancer Centre the Netherlands (IKNL), approximately 100,000 people are diagnosed with cancer in the Netherlands annually. Many of them are treated at Erasmus MC, while linacs at Albert Schweitzer hospital, a satellite in Dordrecht, will also be upgraded.

Luca Incrocci, associate professor of radiation oncology at Erasmus MC, said, "Our history of research and collaboration with Elekta means we know we are receiving commitment and quality. Elekta's equipment and solutions will help us to fulfill our vision of being a recognized leader in treating patients with cancer and to meet our goal to develop research programs to improve treatment results and the quality of life of our patients. "

"Erasmus and Elekta have had a collaborative relationship that goes back 10 years," said Thijs van Bommel, business unit manager for the Netherlands at Elekta AB. "They share our pioneering spirit and focus on patient care, education and scientific research. This mindset helped them easily understand the benefits of Elekta solutions including Versa HD, a flexible and integrated treatment system."

For more information: www.elekta.com

Related Content

California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Philips Unveils IntelliSpace Radiation Oncology at ESTRO 2019
News | Oncology Information Management Systems (OIMS) | April 25, 2019
Philips announced IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity,...
Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...